Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Jul 13, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The VALIANCE Study is looking at the health risks for patients who have same-day noncardiac surgeries, which are operations that don’t involve the heart and allow patients to go home on the same day. As more complex surgeries are done on patients who may have other health issues, this study aims to understand how often serious problems, like heart attacks, happen after these surgeries and what factors might increase those risks. The goal is to develop tools that help identify which patients might be at higher risk before they have surgery.
To participate in the VALIANCE Study, you should be between 45 and 64 years old with at least one risk factor (like high blood pressure or diabetes), or at least 65 years old. You must be scheduled for an elective (planned) noncardiac surgery that will take at least 60 minutes in the operating room, and you need to provide written consent to join. If you decide to participate, you will help researchers gather important information that can improve the safety of same-day surgeries for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 45-64 years of age with at least one risk factor, or ≥65 years of age;
- • undergoing elective noncardiac same-day surgery;
- • planned duration in the operating room 60 minutes or more;
- • provided written consent.
- Exclusion Criteria:
- • intervention does not require the presence of an anesthesiologist;
- • procedure is performed by a nonsurgical specialty (e.g., gastroenterology, pneumology, radio-oncology or radiology);
- • intervention is an ophthalmologic procedure;
- • previously enrolled in the VALIANCE study.
About Centre Hospitalier De L'université De Montréal (Chum)
The Centre Hospitalier de l'Université de Montréal (CHUM) is a leading academic health institution in Canada, dedicated to advancing patient care through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUM is committed to leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. Collaborating with a network of healthcare professionals and researchers, CHUM fosters a rigorous research environment that prioritizes patient safety, ethical standards, and scientific integrity, positioning itself at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Houston, Texas, United States
Hamilton, Ontario, Canada
Sherbrooke, Quebec, Canada
Barcelona, , Spain
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Montreal, Quebec, Canada
Winston Salem, North Carolina, United States
Cleveland, Ohio, United States
Cleveland, Ohio, United States
Toronto, Ontario, Canada
Rotterdam, , Netherlands
Houston, Texas, United States
Patients applied
Trial Officials
Emmanuelle Duceppe, MD, PhD
Principal Investigator
Centre Hospitalier de l'Universite de Montreal (CHUM)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials